Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living FacilitiesMyron S. Cohen, Jason Morris, Jacob Van Naarden et al.|JAMA|2021Cited by 208
Discontinuity in the Transition from Pediatric to Adult Health Care for Patients with Attention–Deficit/Hyperactivity DisorderC. Brendan Montano, Joel Young|Postgraduate Medicine|2012Cited by 49
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of AR19, a Manipulation-Resistant Formulation of Amphetamine Sulfate, in Adults With Attention-Deficit/Hyperactivity DisorderStephen V. Faraone, Joel Young, Elias Sarkis et al.|The Journal of Clinical Psychiatry|2021Cited by 3